Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2010 (2010), Article ID 196307, 7 pages
http://dx.doi.org/10.4061/2010/196307
Research Article

Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study

1Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, 2-2 B6, Yamada-oka, Suita, Osaka 565-0871, Japan
2Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
3Osaka General Medical Center, Osaka Prefectural Hospital Organization, Osaka, Japan

Received 3 July 2010; Accepted 23 July 2010

Academic Editor: Stephen B. Harrap

Copyright © 2010 Ken Sugimoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Kohara, Y. Tabara, J. Nakura et al., “Identification of hypertension-susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension,” Hypertension Research, vol. 31, no. 2, pp. 203–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Watanabe, H. Metoki, T. Ohkubo et al., “Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study,” Hypertension Research, vol. 33, no. 2, pp. 129–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Chapman, G. L. Schwartz, E. Boerwinkle, and S. T. Turner, “Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension,” Kidney International, vol. 61, no. 3, pp. 1047–1055, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Benetos, F. Cambien, S. Gautier et al., “Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals,” Hypertension, vol. 28, no. 6, pp. 1081–1084, 1996. View at Google Scholar · View at Scopus
  5. J. Higaki, S. Baba, T. Katsuya et al., “Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita study,” Circulation, vol. 101, no. 17, pp. 2060–2065, 2000. View at Google Scholar · View at Scopus
  6. T. Asai, T. Ohkubo, T. Katsuya et al., “Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama study,” Hypertension, vol. 38, no. 6, pp. 1321–1324, 2001. View at Google Scholar · View at Scopus
  7. K. Ishikawa, S. Baba, T. Katsuya et al., “T+31C polymorphism of angiotensinogen gene and essential hypertension,” Hypertension, vol. 37, no. 2, pp. 281–285, 2001. View at Google Scholar · View at Scopus
  8. T. Katsuya, Y. Iwashima, K. Sugimoto et al., “Effects of antihypertensive drugs and gene variants in the renin-angiotensin system,” Hypertension Research, vol. 24, no. 4, pp. 463–467, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Sugimoto, A. Hozawa, T. Katsuya et al., “Alpha-adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study,” Journal of Hypertension, vol. 20, no. 9, pp. 1779–1784, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Fu, T. Katsuya, A. Matsuo et al., “Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy,” Hypertension Research, vol. 27, no. 12, pp. 933–938, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Matsuo, T. Katsuya, K. Ishikawa et al., “G2736A polymorphism of thiazide-sensitive Na-Cl cotransporter gene predisposes to hypertension in young women,” Journal of Hypertension, vol. 22, no. 11, pp. 2123–2127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ohashi, N. Ouchi, S. Kihara et al., “Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease,” Journal of the American College of Cardiology, vol. 43, no. 7, pp. 1195–1200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Sugimoto, T. Katsuya, T. Ohkubo et al., “Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama study,” Hypertension Research, vol. 27, no. 8, pp. 551–556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck, “β2- and β3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years,” Circulation, vol. 111, no. 25, pp. 3429–3434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hanasaki, Y. Takemura, K. Fukuo et al., “Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction,” Hypertension Research, vol. 32, no. 4, pp. 261–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Katayama, R. Kawamori, Y. Iwamoto, I. Saito, and K. Kuramoto, “In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study,” Hypertension Research, vol. 31, no. 8, pp. 1499–1508, 2008. View at Google Scholar · View at Scopus
  17. A. I. Lynch, E. Boerwinkle, B. R. Davis et al., “Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension,” Journal of the American Medical Association, vol. 299, no. 3, pp. 296–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. L. Beitelshees, Y. Gong, D. Wang et al., “KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST),” Pharmacogenetics and Genomics, vol. 17, no. 9, pp. 719–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Takahashi and O. Smithies, “Gene targeting approaches to analyzing hypertension,” Journal of the American Society of Nephrology, vol. 10, no. 7, pp. 1598–1605, 1999. View at Google Scholar · View at Scopus
  20. R. P. Lifton, A. G. Gharavi, and D. S. Geller, “Molecular mechanisms of human hypertension,” Cell, vol. 104, no. 4, pp. 545–556, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. L. De Vries, B. Zheng, T. Fischer, E. Elenko, and M. G. Farquhar, “The regulator of G protein signaling family,” Annual Review of Pharmacology and Toxicology, vol. 40, pp. 235–271, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sinnarajah, C. W. Dessauer, D. Srikumar et al., “RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III,” Nature, vol. 409, no. 6823, pp. 1051–1055, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Ingi, A. M. Krumins, P. Chidiac et al., “Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity,” Journal of Neuroscience, vol. 18, no. 18, pp. 7178–7188, 1998. View at Google Scholar · View at Scopus
  24. S. P. Heximer, R. H. Knutsen, X. Sun et al., “Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice,” Journal of Clinical Investigation, vol. 111, no. 4, pp. 445–452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Tang, G. Wang, P. Lu et al., “Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure,” Nature Medicine, vol. 9, no. 12, pp. 1506–1512, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Yang, K. Kamide, Y. Kokubo et al., “Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population,” Journal of Hypertension, vol. 23, no. 8, pp. 1497–1505, 2005. View at Google Scholar · View at Scopus
  27. E. L. Riddle, B. K. Rana, K. K. Murthy et al., “Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives,” Hypertension, vol. 47, no. 3, pp. 415–420, 2006. View at Publisher · View at Google Scholar · View at Scopus